Showing results (1-10 of 703) with videos related to
Sort By:
Pageof 71
Current Opinion in Lipidology|October 1, 1995
Apolipoprotein A-I-containing lipoproteins and atherosclerosisA Leroy, J Dallongeville, J C FruchartThe British Journal of Nutrition|September 1, 2000
Effects of dietary maritime pine (Pinus pinaster)-seed oil on high-density lipoprotein levels and in vitro cholesterol efflux in mice expressing human apolipoprotein A-IG Asset, A Leroy, E Bauge, et al.British Journal of Clinical Practice. Supplement|January 1, 1996
Lipoprotein(a) as a marker for coronary heart diseaseP Duriez, J Dallongeville, J C FruchartBritish Journal of Clinical Practice. Supplement|June 6, 2009
Lipoprotein(a) as a marker for coronary heart diseaseP Duriez, J Dallongeville, J C FruchartEuropean Journal of Clinical Investigation|February 18, 1998
Fat ingestion is associated with increased levels of apoC-III- and apoE-B-containing lipoprotein particles in humansJ Dallongeville, E Baugé, P Lebel, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Lack of triglyceride-lowering properties of fish oil in apolipoprotein e-deficient miceG Asset, E Baugé, J C Fruchart, et al.The Journal of Nutrition|September 10, 1998
Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysisJ Dallongeville, N Marécaux, J C Fruchart, et al.The American Journal of Medicine|June 6, 1994
Fluvastatin reduces levels of plasma apo B-containing particles and increases those of LpA-I. European Fluvastatin Study GroupJ Dallongeville, J C Fruchart, P Pfister, et al.Journal of Internal Medicine. Supplement|January 1, 1994
Effect of fluvastatin on plasma apolipoprotein-B-containing particles, including lipoprotein(a). European Fluvastatin Study GroupJ Dallongeville, J C Fruchart, P Pfister, et al.Metabolism: Clinical and Experimental|June 1, 1996
Very-low-density lipoprotein of uremic patients is a poor substrate for bovine lipoprotein lipase in vitroM Arnadottir, J Dallongeville, J C Fruchart, et al.Pageof 71